524518 Stock Overview
Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Krebs Biochemicals & Industries Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹65.89 |
| 52 Week High | ₹93.20 |
| 52 Week Low | ₹59.30 |
| Beta | 0.47 |
| 1 Month Change | -6.58% |
| 3 Month Change | -11.13% |
| 1 Year Change | -2.95% |
| 3 Year Change | -44.98% |
| 5 Year Change | -32.35% |
| Change since IPO | -75.88% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524518 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -9.2% | -3.4% | -3.7% |
| 1Y | -2.9% | 53.6% | 38.4% |
Return vs Industry: 524518 underperformed the Indian Pharmaceuticals industry which returned 53.6% over the past year.
Return vs Market: 524518 underperformed the Indian Market which returned 38.4% over the past year.
Price Volatility
| 524518 volatility | |
|---|---|
| 524518 Average Weekly Movement | 6.0% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in IN Market | 9.8% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 524518 has not had significant price volatility in the past 3 months.
Volatility Over Time: 524518's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 210 | Jitendra Shah | krebsbiochem.com |
Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications.
Krebs Biochemicals & Industries Limited Fundamentals Summary
| 524518 fundamental statistics | |
|---|---|
| Market cap | ₹1.42b |
| Earnings (TTM) | -₹208.21m |
| Revenue (TTM) | ₹499.09m |
2.8x
P/S Ratio-6.8x
P/E RatioIs 524518 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524518 income statement (TTM) | |
|---|---|
| Revenue | ₹499.09m |
| Cost of Revenue | ₹88.84m |
| Gross Profit | ₹410.25m |
| Other Expenses | ₹618.46m |
| Earnings | -₹208.21m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 21, 2024
| Earnings per share (EPS) | -9.66 |
| Gross Margin | 82.20% |
| Net Profit Margin | -41.72% |
| Debt/Equity Ratio | -173.3% |
How did 524518 perform over the long term?
See historical performance and comparison